Hims & Hers Health, Inc. (HIMS)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNYSEUnited StatesUS4330001060
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Hims & Hers Health, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:14. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 01 Mar 2027 16:00 | -0.05 | — | — | Upcoming |
| 09 Nov 2026 16:00 | 0.06 | -0.14 | -348.6% | Miss |
| 10 Aug 2026 16:00 | -0.05 | -0.37 | -640.0% | Miss |
| 11 May 2026 16:00 | 0.13 | -0.19 | -244.0% | Miss |
| 23 Feb 2026 16:00 | 0.19 | 0.22 | +20.8% | Beat |
| 03 Nov 2025 16:00 | 0.23 | 0.28 | +20.4% | Beat |
| 04 Aug 2025 16:00 | 0.23 | 0.29 | +26.3% | Beat |
| 05 May 2025 16:00 | 0.23 | 0.28 | +24.2% | Beat |
| 24 Feb 2025 16:00 | 0.22 | 0.23 | +4.2% | Beat |
| 04 Nov 2024 16:00 | 0.15 | 0.43 | +187.4% | Beat |
| 05 Aug 2024 16:00 | 0.13 | 0.16 | +28.6% | Beat |
| 06 May 2024 16:00 | 0.08 | 0.10 | +22.5% | Beat |
| 26 Feb 2024 16:00 | 0.06 | 0.05 | -16.1% | Miss |
| 06 Nov 2023 16:00 | 0.05 | 0.06 | +0.3% | In line |
| 07 Aug 2023 16:00 | 0.03 | 0.05 | +72.3% | Beat |
| 08 May 2023 16:00 | 0.02 | 0.03 | +45.5% | Beat |
| 27 Feb 2023 16:00 | -0.06 | -0.05 | +13.6% | Beat |
| 07 Nov 2022 16:00 | -0.06 | -0.09 | -49.9% | Miss |
| 08 Aug 2022 16:00 | -0.06 | -0.10 | -68.7% | Miss |
| 09 May 2022 16:00 | -0.06 | -0.08 | -43.0% | Miss |
| 22 Feb 2022 16:00 | -0.06 | -0.10 | -58.2% | Miss |
| 10 Nov 2021 16:00 | -0.06 | -0.10 | -59.6% | Miss |
| 11 Aug 2021 16:00 | -0.06 | -0.09 | -58.7% | Miss |
| 17 May 2021 07:00 | -0.07 | -0.28 | -330.3% | Miss |
| 18 Mar 2021 16:00 | -0.06 | -0.05 | +11.5% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 2.3B | +59.0% | 128.4M | 5.5% | 0.51 | -3.8% | 57.4M |
| 2024 | 1.5B | +69.3% | 126M | 8.5% | 0.53 | +581.8% | 198.3M |
| 2023 | 872M | +65.5% | -23.5M | -2.7% | -0.11 | +65.6% | 47M |
| 2022 | 526.9M | — | -65.7M | -12.5% | -0.32 | — | -33.8M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 25.25 | 25.67 | 18.40 | 19.40 | -25.38% | 148,465,109 | |
| 02 Nov 2026 – 06 Nov 2026 | 27.97 | 28.66 | 22.88 | 26.00 | -6.07% | 60,608,400 | |
| 26 Oct 2026 – 30 Oct 2026 | 27.51 | 30.13 | 26.68 | 27.68 | -0.11% | 43,912,200 | |
| 19 Oct 2026 – 23 Oct 2026 | 28.49 | 30.02 | 27.30 | 27.71 | -1.28% | 42,335,000 | |
| 12 Oct 2026 – 16 Oct 2026 | 30.92 | 31.79 | 26.33 | 28.07 | -9.22% | 57,113,100 | |
| 05 Oct 2026 – 09 Oct 2026 | 28.91 | 31.45 | 27.49 | 30.92 | +6.62% | 53,350,300 | |
| 28 Sep 2026 – 02 Oct 2026 | 29.00 | 31.03 | 28.30 | 29.00 | -1.43% | 45,649,100 | |
| 21 Sep 2026 – 25 Sep 2026 | 28.50 | 31.81 | 27.31 | 29.42 | +5.11% | 61,884,000 | |
| 14 Sep 2026 – 18 Sep 2026 | 27.38 | 29.44 | 27.14 | 27.99 | +1.74% | 45,120,300 | |
| 08 Sep 2026 – 11 Sep 2026 | 27.73 | 28.33 | 26.73 | 27.51 | -0.72% | 31,667,800 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- FTC Widens Its Hims & Hers Suit as Five States Join Over Privacy and Billing (opens in a new tab) TIKR · 11 Nov 2026 17:15
- Hims & Hers Q3 Earnings Miss Estimates, Gross Margin Down (opens in a new tab) Zacks · 11 Nov 2026 16:38
- Hims & Hers Health: The Thesis Is Getting Shaky (Rating Downgrade) (opens in a new tab) SeekingAlpha · 11 Nov 2026 13:39
- Hims & Hers Faces A ‘Transition Year’ Amid Increasing AI Investments, Says KeyBanc – Expects Lower Pricing To Weigh On FY2027-2028 Earnings Outlook (opens in a new tab) Stocktwits · 11 Nov 2026 12:44
- KeyBanc Waits for a Growth Inflection at Hims & Hers (opens in a new tab) GuruFocus.com · 11 Nov 2026 11:40
- Hims & Hers Health Faces Expanded FTC Lawsuit Over Privacy, Billing Practices (opens in a new tab) MT Newswires · 11 Nov 2026 09:31
- Five US states join FTC suit against Hims & Hers over privacy practices (opens in a new tab) Reuters · 11 Nov 2026 01:38
- Hims & Hers (HIMS) Stock Price Faces Q3 Results Margin Reckoning (opens in a new tab) Simply Wall St. · 11 Nov 2026 01:10
- HIMS Stock Faces Dual Blow From Expanded FTC Privacy Lawsuit After Selloff Driven By Q3 Subscriber Loss (opens in a new tab) Stocktwits · 10 Nov 2026 23:10
- HIMS Q3 Earnings Call Highlights Marketing Reset and Margin Pressure (opens in a new tab) Zacks · 10 Nov 2026 19:20
- Why Is Hims & Hers Health (HIMS) Bringing Andrew Huberman Onto Its Board? (opens in a new tab) Simply Wall St. · 10 Nov 2026 19:11
- Hims & Hers Stocks Plunge 15.37% as Margin Squeeze Forces EBITDA Guidance Cut (opens in a new tab) GuruFocus.com · 10 Nov 2026 18:55
- Jefferies Maintains Hold on Hims & Hers Health, Lowers Price Target to $24 (opens in a new tab) Benzinga · 10 Nov 2026 17:51
- Hims & Hers Health Inc (HIMS) (Q3 2026) Earnings Call Highlights: Revenue Surges 49% to ... (opens in a new tab) GuruFocus.com · 10 Nov 2026 17:03
- HIMS May See Heightened ‘Gyrations’ As Weight-Loss Drug Trends Fuel Subscriber Uncertainty, Jefferies Warns – Stock Hits 7-Month Lows (opens in a new tab) Stocktwits · 10 Nov 2026 16:11
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 19.73 USD
- Market cap
- 4.5B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow HIMS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.